CompoAtlas

Awakening Tea

Natural health product licensed in Canada

Licence holder
The Algonquin Tea Company Inc.
NPN or DIN-HM
80081877
Status
Active licence
Licence date
15 December 2017
Revision date
Not provided
Form
Sachet de thé
Route of administration
Orale
Application type
Traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Mentha x piperita

Source : Plante

400 mgNot calculated
Urtica dioica

Source : Sommité

200 mgNot calculated
Medicago sativa

Source : Sommité

100 mgNot calculated
Astragalus membranaceus

Source : Racine

20 mgNot calculated
Angelica archangelica

Source : Feuille

50 mgNot calculated
Panax quinquefolius

Source : Racine

10 mgNot calculated
Rhododendron groenlandicum

Source : Feuille

100 mgNot calculated
Filipendula ulmaria

Source : Herb flowering

40 mgNot calculated

Non-medicinal ingredients

Feuilles séchées de Mentha spicata (menthe verte)

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 tea bag3 days

Uses authorised in Canada

Text supplied in English because no French text is available.

Traditionally used in Herbal Medicine to aid digestion. Traditionally used in Herbal Medicine to help relieve flatulent dyspepsia.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80081877

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line